(Q52071713)

English

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.

scientific article published in November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Steven M. Haffner

5

object named as

Haffner SM

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

Ralph B D'Agostino Jr

2

object named as

D'Agostino R Jr

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

author name string

Festa A

1

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

Rautaharju P

3

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

Mykkänen L

4

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

86

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

10

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

1117-1122

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

QT interval as a cardiac risk factor in a middle aged population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Effect of obesity and regional adiposity on the QTc interval in women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

The long QT syndrome: ion channel diseases of the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Assessment of insulin sensitivity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Coated Charcoal Immunoassay of Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Role of oxidative stress in development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901170-X

7 January 2021

Identifiers

10.1016/S0002-9149(00)01170-X

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/11074210

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52071713&oldid=2138732590"